Australia markets open in 1 hour 8 minutes

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
34.09+0.49 (+1.46%)
At close: 04:00PM EST
34.09 0.00 (0.00%)
After hours: 04:01PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
298,231
171,546
187,802
195,892
Cost of revenue
87,379
42,180
45,465
60,897
Gross profit
210,852
129,366
142,337
134,995
Operating expenses
Research development
30,658
51,275
30,785
36,810
Selling general and administrative
102,801
75,322
78,598
76,370
Total operating expenses
133,459
126,597
109,383
113,180
Operating income or loss
77,393
2,769
32,954
21,815
Interest expense
2,506
1,635
2,577
2,686
Total other income/expenses net
-25,699
-6,242
-8,262
700
Income before tax
49,353
-4,548
22,677
21,998
Income tax expense
28,072
4,079
10,688
7,685
Income from continuing operations
21,281
-8,627
11,989
14,313
Net income
21,281
-8,627
11,989
14,313
Net income available to common shareholders
21,281
-8,627
11,989
14,313
Basic EPS
-
-0.66
0.89
1.04
Diluted EPS
-
-0.66
0.87
1.01
Basic average shares
-
13,051
13,482
13,755
Diluted average shares
-
13,051
13,771
14,139
EBITDA
-
847
30,020
29,335